Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01417286 · ClinicalTrials.gov registry record · Phase 2
Accelerated Radiation Therapy After Surgery in Treating Patients With Breast Cancer
A Phase 2 study, sponsored by Rutgers, The State University of New Jersey.
- Completed
- Registry status
- Phase 2
- Development phase
- 69
- Enrollment target
NCT01417286 is a Phase 2 study that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 69 participants.
The verdict
NCT01417286, a Phase 2 study, has completed, sponsored by Rutgers, The State University of New Jersey.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 69 participants
- Enrollment target
Study Summary
This phase II trial studies how well giving accelerated radiation therapy (RT) after surgery works in treating patients with breast cancer. RT uses high energy x rays to kill tumor cells. Giving RT after surgery may kill any remaining tumor cells
Interventions
- RADIATION External beam radiation therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 69 participants |
| Start Date | 2010-12-21 |
| Est. Completion | 2020-02-20 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01417286
The ClinicalTrials.gov registry entry for NCT01417286 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 69 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which External beam radiation therapy is the first listed.
NCT01417286 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01417286 about?
NCT01417286 is a clinical study titled "Accelerated Radiation Therapy After Surgery in Treating Patients With Breast Cancer". This phase II trial studies how well giving accelerated radiation therapy (RT) after surgery works in treating patients with breast cancer. RT uses high energy x rays to kill tumor cells. Giving RT after surgery may kill any remaining tumor cells
What is the current status of trial NCT01417286?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 69 participants. The study started on 2010-12-21. Estimated completion is 2020-02-20.
What interventions are being tested in trial NCT01417286?
The interventions under investigation include: External beam radiation therapy (RADIATION).
Who is sponsoring clinical trial NCT01417286?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.